Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1995-06-07
1997-03-18
Owens, Amelia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
549220, A61K 31665, C07F 928
Patent
active
056123230
ABSTRACT:
##STR1## and pharmaceutically acceptable salts thereof wherein Y is a single bond, --CH.sub.2 --, --C(O)--, --S-- or --N(R.sup.11)--; and R.sup.1 to R.sup.6 are as defined herein. These compounds have potassium channel activating activity and are useful, therefore for example, as cardiovascular agents.
REFERENCES:
patent: 3330838 (1967-07-01), Augstein et al.
patent: 3812157 (1974-05-01), Lin et al.
patent: 3953506 (1976-04-01), Spicer et al.
patent: 4238501 (1980-12-01), Kabbe et al.
patent: 4251537 (1981-02-01), Evans
patent: 4363811 (1982-12-01), Evans et al.
patent: 4366163 (1982-12-01), Evans et al.
patent: 4391815 (1983-07-01), Evans
patent: 4428881 (1984-01-01), Hedrich et al.
patent: 4481213 (1984-11-01), Evans
patent: 4568692 (1986-02-01), Evans
patent: 4571406 (1986-02-01), Evans et al.
patent: 4575511 (1986-03-01), Evans et al.
patent: 4602022 (1986-07-01), Cozzi et al.
patent: 4659737 (1987-04-01), Kabbe et al.
patent: 4687779 (1987-08-01), Evans
patent: 4734421 (1988-03-01), Hammond et al.
patent: 4772603 (1988-09-01), Evans
patent: 4782083 (1988-11-01), Cassidy et al.
patent: 4831050 (1989-05-01), Cassidy et al.
patent: 4904784 (1990-02-01), Evans et al.
patent: 4925839 (1990-05-01), Quagliato et al.
patent: 4943582 (1990-07-01), Evans et al.
patent: 4971982 (1990-11-01), Attwood et al.
patent: 4988723 (1991-01-01), Shiokawa et al.
patent: 5006523 (1991-04-01), Atwal
patent: 5011837 (1991-04-01), Atwal et al.
patent: 5013853 (1991-05-01), Gericke et al.
patent: 5021432 (1991-06-01), Yamanaka et al.
patent: 5028711 (1991-07-01), Stenzel et al.
patent: 5053427 (1991-10-01), Stemp et al.
patent: 5061813 (1991-10-01), Atwal
patent: 5071871 (1991-12-01), Blarer et al.
patent: 5082858 (1992-01-01), Garcia et al.
patent: 5095016 (1992-03-01), Ohtuka et al.
patent: 5096914 (1992-03-01), Stenzel et al.
patent: 5104890 (1992-04-01), Shiokawa et al.
patent: 5140031 (1992-08-01), Atwal et al.
patent: 5143924 (1992-09-01), Gericke et al.
patent: 5143936 (1992-09-01), Yamanaka et al.
patent: 5145985 (1992-09-01), Timar et al.
patent: 5210234 (1993-05-01), Evans et al.
patent: 5238937 (1993-08-01), Gericke et al.
patent: 5254555 (1993-10-01), Stemp et al.
patent: 5268386 (1993-12-01), Harada et al.
patent: 5276168 (1994-01-01), Atwal
patent: 5278169 (1994-01-01), Atwal
patent: 5286753 (1994-02-01), Schaus et al.
patent: 5310750 (1994-05-01), Berge et al.
patent: 5310932 (1994-05-01), Atwal et al.
patent: 5317029 (1994-05-01), Inazu et al.
patent: 5318969 (1994-06-01), Yamanaka et al.
patent: 5374643 (1994-12-01), Atwal et al.
patent: 5393771 (1995-02-01), Atwal
patent: 5401848 (1995-03-01), Atwal
A.P. Terent'ev et al., "Optically Active Isocyanates. III. Synthesis and Spectropolarimetric Study of Optically Active N-derivative of Urea", Chemical Abstracts, vol. 71, Abstract No. 69992h, p. 250 (1969).
J. Bermudez et al., "5-Hydroxytryptamine (5-HT.sub.3) Receptor Antagonists. 2. 1-Indolinecarboxamides", J. Med. Chem., vol. 33, pp. 1929-1932 (1990).
P.D. Leeson et al., "4-Amido-2-carboxytetrahydroquinolines, Structure-activity Relationships for Antagonism at the Glycine Site of the NMDA Receptor", J. Med. Chem., vol. 35, pp. 1954-1968 (1992).
J.L. Hughes et al., "Cardiovascular Activity of Aromatic Guanidine Compounds", J. Med. Chem., vol. 18, No. 11, pp. 1077-1088 (1975).
M. Mazza et al., "N-Acilindoline Ad Attivita Fitotossica", Farmaco. Ed. Sci., vol. 31, No. 10, pp. 746-754 (1976).
T. Sekiya et al., "Benzene-condensed Cyclic Amine .beta.-amino Carboxamides as Antichycardiacs and Vasodilators", Chemical Abstracts, vol. 113, p. 694 (1990).
R. Albrecht et al., "Chemotherapeutic Nitroheterocycles. XI (1). Indanylamides and Indanylesters of 5-nitrofurancarboxylic Acids and Analogous Compounds as Antimicrobial Agents", Chimie Therapeutique, vol. 7, No. 1, pp. 9-13 (1972).
H.J. Petersen et al., "Synthesis and Hypotensive Activity of N-Alkyl-N-cyano-N'-pyridylguanidines", J. of Med. Chem., vol. 21, No. 8, pp. 773-781 (1978).
V.A. Ashwood et al., "Synthesis and Antihypertensive Activity of 4-(Cyclic amido)-2H-1-benzopyrans", J. Med. Chem., 29, pp. 2194-2201 (1986).
C.R. Rasmussen et al., "Improved Procedures for the Preparation of Cycloalky-Arylalkyl-, and Arylthioureas", Synthesis, pp. 456-459 (1988).
V.V. Mozolis et al., "Preparation of N-Substituted Thiourea", Russian Chem. Reviews, 42(7), pp. 587-595 (1973).
J.M. Evans et al., "Synthesis and Antihypertensive Activity of Substituted trans-4-Amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ols", J. Med. Chem., 26, pp. 1582-1589 (1983).
R.W. Lang et al., "Synthesis of Selectively Trifluoromethylated Pyridine Derivatives as Potential Antihypertensives", Helvetica Chimica Acta, vol. 72, pp. 596-601 (1988).
P. Sebok et al., "Selective synthesis of Analogues of the Natural Precocenes, Synthesis and Regioselective (-Alkylation of 6-Chloro-and 6-Tert-Butyl-7,8-Dihyedroxy-2,2-Dimethyl-4-Chromanones", Heterocycles, 27, pp. 2595-2607 (1988).
P. Teixidor et al., "Improved Preparation of Precocene II, Unexpected Results in the Reduction of Alkoxy Substituted Acetophenones and 4-Chromanones with Sodium Borohydride", Heterocycles, 27, pp. 2459-2465 (1988).
A. Banerji et al., "Enolates of O-Hydroxyacetophenones: Novel Synthesis of 2,2-Dialkyl-4-Chromanones", Tetrahedron Letters, No. 38, pp. 2685-2686 (1979).
G. Ariamala et al., "A Simple Route for the Synthesis of 4-Chlorochromanes and Chroman-4-one", Tetrahedron Letters, 29, No. 28, pp. 3487-3488 (1988).
Bristol--Myers Squibb Company
Owens Amelia
Park Ellen K.
LandOfFree
Phosphinic ester substituted benzopyran derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phosphinic ester substituted benzopyran derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phosphinic ester substituted benzopyran derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1706419